Knowledge (XXG)

Fosun Pharma

Source 📝

2164: 819:, Fosun Pharmaceutical made the largest Indian corporate takeover by a Chinese company. The parties have now reached agreement that Fosun Pharma will acquire an approximate 74% stake in Gland Pharma for no more than US$ 1,091.30 million, including paying no more than US$ 25 million contingent consideration for Gland Pharma's Enoxaparin sales in the U.S. market. Despite the offer was revised in 2017 to seek approval from Indian regulators. In October 2017, the acquisition of 74% stake of Gland Pharma was completed. 903:
showed BNT162b2 to have a better safety profile. BNT162b2 had missed an opportunity window to get tested in China, as another vaccine Fosun had started trials of BNT162b1 before trials data showed BNT162b2 as being the safer vaccine. Fosun's Chief Medical Officer Hui Aimin said that he didn't regret testing BNT162b1 without waiting for all the data. “For ordinary vaccines, it does not matter if you wait for a few days, or a month,” Hui said. “But for
47: 2098: 284: 267: 240: 866:, was approved by the NMPA, and received CE certification from the European Union, as an in vitro diagnostic reagent. By August 2020 Fosun Pharma donated medical masks, protective clothing, medical non-invasive ventilators, negative pressure ambulances, and other equipment and supplies valued at more than RMB 30 million to the epidemic area. 902:
On 5 August, Fosun and BioNTech announced an initial Phase 1 trial in China that enrolled 144 volunteers to evaluate the safety and immunogenicity of BNT162b1. On 4 November, Fosun announced it would stop further trials of BNT162b1, as results from trials in Germany, United States, and China all
1931:
Walsh, Edward E.; Frenck, Robert; Falsey, Ann R.; Kitchin, Nicholas; Absalon, Judith; Gurtman, Alejandra; Lockhart, Stephen; Neuzil, Kathleen; Mulligan, Mark J.; Bailey, Ruth; Swanson, Kena A. (28 August 2020). "RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study".
893:
to scale-up manufacturing capacity to provide worldwide supply in response to the pandemic. BioNTech and Pfizer would commercialize the vaccine worldwide except in China, which was already covered by BioNTech's agreement with Fosun.
1905: 1878: 1853: 2152: 2364: 2369: 2354: 919:
trials by Pfizer since July. Fosun would apply for a bridge study on BNT162b2, designed to test if the large trial data done overseas could be extrapolated to the populace of China.
780:). In 2008, a year before the initial public offering of Sinopharm Group, Fosun Pharmaceutical owned the direct parent company of Sinopharm Group, Sinopharm Industrial Investment ( 2384: 2234: 2145: 2379: 990:, still served as non-executive directors of Fosun Pharmaceutical. As of 31 July 2019, the market capitalization of the H share of Fosun Pharma was 1800: 1730:"VOLUNTARY ANNOUNCEMENT - ENTERING INTO SECURITIES PURCHASE AGREEMENT IN RELATION TO THE ACQUISITION OF THE ENTIRE EQUITY INTEREST IN TRIDEM PHARMA S.A.S" 1512: 2394: 2349: 2168: 2138: 2070: 2010: 1647: 1114: 1984: 1271: 937:
On 6 November, Fosun was hopeful BNT162b2 could be available in China as soon as it became available in the United States and Europe. On 20 November,
968:
As of 31 December 2017, there was 2,011,190,000 number of A shares and 483,941,000 number of H shares, for a total of 2,495,131,000, which
2130: 841:, "an Africa-focused French drug distributor", for not more than €63 million. In January 2021, the company entered into a partnership with 2404: 1775: 2359: 2264: 2219: 2284: 1022: 789: 111: 2316: 2239: 2209: 915:
Fosun said it would instead focus on seeking Chinese regulatory approval for BioNTech's other candidate BNT162b2 which was already in
97: 982:
As of 31 December 2017, co-founder of Fosun High Technology and now co-owner of the parent company of Fosun International,
1826: 2249: 598: 2259: 1214: 1755: 1622:"JOINT ANNOUNCEMENT - DISCLOSEABLE TRANSACTION - PROGRESS ON ACQUISITION OF THE CONTROLLING INTEREST IN GLAND PHARMA LIMITED" 1400: 1336: 1047: 521: 454: 387: 1039: 781: 773: 742: 734: 726: 705: 697: 679: 507: 440: 373: 2399: 942: 863: 2244: 2214: 827: 2389: 1297: 972:'s wholly owned subsidiary, Fosun High Technology, owned 936,575,490 and 9,989,000 number of shares respectively. 2269: 2199: 1879:"Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development" 916: 1242: 2254: 1729: 1674: 1648:"Fosun unit Sisram Medical's Hong Kong share offer draws strong investor interest, nets company US$ 88 million" 1621: 1432: 1119: 1086: 958: 664: 625: 107: 31: 1958: 1906:"BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China" 1486: 2409: 2311: 1457: 667: 93: 803: 733:) was incorporated in January 1994. The majority shareholders in December 1994 were Fosun High Technology ( 2279: 762: 2274: 2229: 1164: 250: 2037: 1142: 633: 123: 2194: 1933: 823: 322: 2321: 969: 796: 618: 295: 164: 2107: 1702: 1594: 1540: 834: 721:
Shanghai Fortune Industrial Joint-Stock Co., Ltd. was incorporated in 1998, but its predecessor,
638: 1938: 1801:"Coronavirus Tests From Fosun Pharma, Osang Healthcare Receive FDA Emergency Use Authorization" 1368: 2374: 2179: 2045: 842: 1567: 2224: 991: 976: 904: 544: 477: 410: 276: 46: 2296: 2289: 1026: 1010: 815: 769: 312: 2103: 1025:
itself was also transliterated as Sinopharm Group before the listing of its subsidiary,
1627:(Press release). Shanghai: Fosun International, Fosun Pharmaceutical. 17 September 2017 1038:
Despite it is a namesake of the former name of Fosun Pharmaceutical, Fosun Industrial (
983: 954: 807: 750: 881:
received a $ 135 million investment from Fosun in exchange for 1.58 million shares in
2343: 2306: 2189: 2184: 830:. As of 31 December 2017, Fosun Pharma owned Sisram Medical 52.83% shares. 629: 80: 1513:"Fosun and partners buy US hospital operator Chindex for US$ 433m in sweetened deal" 1189: 17: 1959:"China's Fosun to end BioNTech's COVID-19 vaccine trial, seek approval for another" 886: 859: 754: 551: 484: 417: 826:(parent company of Alma Lasers) was spin-off as a separate listed company on the 2326: 2204: 987: 758: 1760: 862:
detection kit (PCR) which received emergency use authorization (EUA) from the
610: 303: 232: 2049: 2011:"Fosun hopes to launch Covid-19 vaccine in China at same time as US, Europe" 1386: 927: 833:
In October 2017 Fosun Pharmaceutical, via subsidiaries Fosun Pharmaceutical
799:(parent company of Fosun High Technology), became a listed company in 2007. 1985:"Fosun Pharma to supply Covid-19 vaccine to Hong Kong, Macau once approved" 1854:"BioNTech in China alliance with Fosun over coronavirus vaccine candidate" 907:, how many more people would have died had you waited just for one day?” 882: 878: 871: 243: 654:
Chen Qiyu is co-CEO of Fosun International and Chairman of Fosun Pharma.
962: 671: 1251:] (in Chinese (China)). Shanghai Fortune Industrial. 23 June 1998 938: 890: 712:). The company also shorten the transliteration of the legal suffix 2038:"Pfizer Applies for Emergency F.D.A. Approval for Covid-19 Vaccine" 1756:"Hong Kong's AI drug discovery firm Insilico closes $ 60M Series D" 1310:(in Chinese (China)). Shanghai Fortune Industrial. 16 February 2000 802:
In 2014 Fosun Pharma was part of a consortium to acquire US-listed
788:) instead; the majority owner of the joint venture was state-owned 2301: 2163: 1272:"Fosun Pharmaceutical begins taking IPO orders from big investors" 931: 926:-listed Jacobson Pharma to supply 10 million doses of BNT162b2 to 259: 1190:"Wu Yifang, Shanghai Fosun Pharmaceutical: Profile and Biography" 1115:"Fosun Pharma chief cites Huawei as model for overseas expansion" 889:
BNT162b2 in China. Also, BioNTech announced a collaboration with
1735:(Press release). Shanghai: Fosun Pharmaceutical. 29 October 2017 923: 674:
in 2012. The English name of the company was initially known as
2134: 2123: 581: 1466:(in Chinese (Hong Kong)). Hong Kong: Next Media. 23 June 2008 922:
In early August, Fosun and BioNTech signed an agreement with
617:) is a Chinese pharmaceutical company. It is mostly owned by 1703:"Fosun Pharmaceutical to buy French drug distributor Tridem" 1438:(Press release). Shanghai: Fosun International. 20 June 2008 845:, to facilitate the latter's entry into the Chinese market. 837:
and Fosun Industrial bought Tridem Pharma, according to the
1776:"Fosun Pharma gets FDA EUA nod for COVID-19 detection kit" 1592:
Weinland, Don (18 September 2017). Written at Hong Kong.
424:
Shàng hǎi fù xīng yī yào (jí tuán) gǔ fèn yǒu xiàn gōng sī
1413:(in Chinese (China)). Fosun Pharmaceutical. 25 March 2010 2073:. Hong Kong Exchanges and Clearing Limited. 31 July 2019 636:. The company was ranked 1,840th in 2020 edition of the 1538:
Waldmeir, Patti (22 April 2014). Written at Shanghai.
885:
and the future development and marketing rights of the
663:
Fosun Pharmaceutical is a listed company which started
1215:"Interview: Chen Qiyu – Chairman, Fosun Pharma, China" 2235:
Lijun International Pharmaceutical (Holding) Co. Ltd.
1743:– via Hong Kong Exchanges and Clearing website. 1690:– via Hong Kong Exchanges and Clearing website. 1635:– via Hong Kong Exchanges and Clearing website. 1446:– via Hong Kong Exchanges and Clearing website. 1349:(in Chinese (China)). Fosun Industrial. 24 April 2004 1102:– via Hong Kong Exchanges and Clearing website. 556: 489: 422: 1331: 1329: 1327: 1325: 1081: 1079: 1077: 1075: 1073: 1071: 975:
Fosun High Technology also once owned 23.45% of the
768:In 2003 Fosun Pharmaceutical acquired 49% stake of 651:
Wu Yifang is the president and CEO of Fosun Pharma.
576: 550: 543: 538: 520: 506: 501: 483: 476: 471: 453: 439: 434: 416: 409: 404: 386: 372: 367: 302: 291: 274: 257: 230: 222: 193: 179: 157: 149: 132: 78: 70: 53: 1701: 1595:"Fosun revises its offer for India's Gland Pharma" 1593: 1539: 1013:was previously transliterated as Sinopharm Holding 2036:Weiland, Noah; Thomas, Katie (20 November 2020). 696:), as well as changing the name from Industrial ( 676:Shanghai Fortune Industrial Joint-Stock Co., Ltd. 2365:Companies listed on the Hong Kong Stock Exchange 898:Initial Investment in BioNTech and Early Testing 795:An intermediate parent company of Fosun Pharma, 2370:Companies listed on the Shanghai Stock Exchange 1682:. Sisram Medical. 25 April 2018. pp. 31–32 961:which only traded in mainland China as well as 642:, a list of top listed companies of the world. 607:Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 40:Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 2355:Multinational companies headquartered in China 741:) and its parent company Guangxin Technology ( 718:from Joint-Stock Co., Ltd. to just Co., Ltd.. 2146: 1827:"Fosun Pharma Announces 2020 Interim Results" 713: 687: 526: 512: 459: 445: 392: 378: 8: 2385:Pharmaceutical companies established in 1994 1421:– via Shanghai Stock Exchange website. 1357:– via Shanghai Stock Exchange website. 1318:– via Shanghai Stock Exchange website. 1237: 1235: 941:applied for emergency use approval from the 692:was later changed from Fortune to Fosun (as 39: 1548:. Additional reporting by Zhang Yan. London 1487:"Fosun increases price range of IPO shares" 2260:Shanghai Pharmaceuticals Holding Co., Ltd. 2153: 2139: 2131: 535: 468: 401: 45: 38: 1937: 1249:Prospectus of Shanghai Fortune Industrial 1145:(Microsoft Excel). China Securities Index 1541:"TPG snaps up Chinese hospital operator" 953:Fosun Pharmaceutical had two classes of 1067: 1003: 979:(SSE:100196) of Fosun Pharma in 2003. 822:In September 2017, Israeli subsidiary 2380:Chinese companies established in 1994 1953: 1951: 1949: 1519:. Hong Kong. Bloomberg. 23 April 2014 1094:. Fosun Pharmaceutical. 17 April 2018 7: 2265:Shenzhen Kangtai Biological Products 2220:Hebei Yuxing Bio-Engineering Co. Ltd 749:); Guangxin Technology was owned by 2285:China National Pharmaceutical Group 1377:(in Chinese (China)). 4 August 2014 1023:China National Pharmaceutical Group 806:, which owned private hospitals in 790:China National Pharmaceutical Group 723:Shanghai Fortune Industrial Company 628:of the company is a constituent of 2317:Yangtze River Pharmaceutical Group 2240:Kunming Pharmaceutical Corporation 2210:Guizhentang Pharmaceutical Company 1568:"Fosun Pharma--News--News Content" 287:CN¥25.270 billion (2017) 270:CN¥61.914 billion (2017) 25: 2395:Civilian-run enterprises of China 2350:Pharmaceutical companies of China 2169:Pharmaceutical companies of China 2250:North China Pharmaceutical Group 2162: 2096: 1054:) was incorporated in Hong Kong. 965:which only traded in Hong Kong. 911:Regulation and Commercialization 858:The company developed 2019-nCoV 599:consolidated financial statement 283: 282: 266: 265: 239: 238: 1852:Ludwig Burger (15 March 2020). 1646:He, Laura (18 September 2017). 1165:"Shanghai Fosun Pharmaceutical" 594:Footnotes / references 313:Sinopharm Industrial Investment 1904:SE, BioNTech (5 August 2020). 1143:"SSE MidCap Constituents List" 1051: 1043: 785: 777: 746: 738: 730: 709: 701: 686:), but the transliteration of 683: 557: 527: 513: 490: 460: 446: 423: 393: 379: 27:Chinese pharmaceutical company 1: 2405:1998 initial public offerings 1939:10.1101/2020.08.17.20176651v2 1270:Chan, Ray (16 October 2012). 1029:(formerly Sinopharm Holding). 1485:Chan, Carol (27 June 2007). 943:Food and Drug Administration 2360:Companies based in Shanghai 2245:Nanjing Ange Pharmaceutical 2215:Harbin Pharmaceutical Group 2071:"List of H Share Companies" 1673:"Report of the Directors". 828:Stock Exchange of Hong Kong 60:Shanghai Fortune Industrial 2426: 1754:Liao, Rita (6 June 2022). 813:In 2016, according to the 29: 2270:Shijiazhuang Pharma Group 2200:Guangzhou Pharmaceuticals 2175: 1710:. London. 30 October 2017 1113:Li, Jane (3 April 2018). 714: 688: 632:as well as its sub-index 592: 572: 568: 534: 502:former Chinese short name 467: 400: 363: 359: 63:Shanghai Fosun Industrial 44: 2255:Salubris Pharmaceuticals 2015:South China Morning Post 1989:South China Morning Post 1652:South China Morning Post 1517:South China Morning Post 1491:South China Morning Post 1458: 1433:"Connection Transaction" 1401: 1369: 1337: 1298: 1276:South China Morning Post 1243: 1120:South China Morning Post 522:Traditional Chinese 455:Traditional Chinese 388:Traditional Chinese 32:Shanghai Pharmaceuticals 30:Not to be confused with 2312:Xiangxue Pharmaceutical 1910:GlobeNewswire News Room 1780:www.biospectrumasia.com 1259:– via jrj.com.cn. 668:initial public offering 508:Simplified Chinese 441:Simplified Chinese 374:Simplified Chinese 2280:Simcere Pharmaceutical 1244:上海复星实业股份有限公司(筹)招股说明书概要 2275:Sihuan Pharmaceutical 2230:Jilin Aodong Medicine 2109:Fosun Pharmaceutical 804:Chindex International 704:) to Pharmaceutical ( 165:Fosun High Technology 2195:Fosun Pharmaceutical 1883:www.businesswire.com 317:(joint venture, 49%) 124:SSE MidCap Component 18:Fosun Pharmaceutical 2400:Fosun International 2322:Yunnan Baiyao Group 1572:www.fosunpharma.com 1370:国药集团复星联合成立首家混合所有制药企 1048:traditional Chinese 970:Fosun International 870:COVID-19 Vaccine - 797:Fosun International 619:Fosun International 169:Guangxin Technology 41: 2106:has a profile for 2042:The New York Times 1676:2017 Annual Report 1407:2009 Annual Report 1343:2003 Annual Report 1304:1999 Annual Report 1088:2017 Annual Report 1040:simplified Chinese 877:On 17 March 2020, 639:Forbes Global 2000 435:Chinese short name 2390:Vaccine producers 2337: 2336: 2180:CanSino Biologics 2112: 2017:. 6 November 2020 1965:. 4 November 2020 1462:. "財話短說" column. 905:COVID-19 vaccines 854:Initial Responses 843:Insilico Medicine 604: 603: 564: 563: 545:Standard Mandarin 497: 496: 478:Standard Mandarin 430: 429: 411:Standard Mandarin 355: 354: 226:private hospitals 218: 217: 120: 119: 16:(Redirected from 2417: 2225:Huadong Medicine 2167: 2166: 2155: 2148: 2141: 2132: 2127: 2126: 2124:Official website 2110: 2100: 2099: 2083: 2082: 2080: 2078: 2067: 2061: 2060: 2058: 2056: 2033: 2027: 2026: 2024: 2022: 2007: 2001: 2000: 1998: 1996: 1991:. 27 August 2020 1981: 1975: 1974: 1972: 1970: 1955: 1944: 1943: 1941: 1928: 1922: 1921: 1919: 1917: 1901: 1895: 1894: 1892: 1890: 1875: 1869: 1868: 1866: 1864: 1849: 1843: 1842: 1840: 1838: 1833:. 26 August 2020 1823: 1817: 1816: 1814: 1812: 1797: 1791: 1790: 1788: 1786: 1772: 1766: 1765: 1751: 1745: 1744: 1742: 1740: 1734: 1726: 1720: 1719: 1717: 1715: 1705: 1698: 1692: 1691: 1689: 1687: 1681: 1670: 1664: 1663: 1661: 1659: 1643: 1637: 1636: 1634: 1632: 1626: 1618: 1612: 1611: 1609: 1607: 1597: 1589: 1583: 1582: 1580: 1578: 1564: 1558: 1557: 1555: 1553: 1543: 1535: 1529: 1528: 1526: 1524: 1509: 1503: 1502: 1500: 1498: 1482: 1476: 1475: 1473: 1471: 1454: 1448: 1447: 1445: 1443: 1437: 1429: 1423: 1422: 1420: 1418: 1412: 1397: 1391: 1390: 1384: 1382: 1365: 1359: 1358: 1356: 1354: 1348: 1333: 1320: 1319: 1317: 1315: 1309: 1294: 1288: 1287: 1285: 1283: 1267: 1261: 1260: 1258: 1256: 1239: 1230: 1229: 1227: 1225: 1211: 1205: 1204: 1202: 1200: 1186: 1180: 1179: 1177: 1175: 1161: 1155: 1154: 1152: 1150: 1139: 1133: 1132: 1130: 1128: 1110: 1104: 1103: 1101: 1099: 1093: 1083: 1055: 1053: 1045: 1036: 1030: 1020: 1014: 1008: 994:12,943,004,725. 977:convertible bond 787: 779: 748: 740: 732: 717: 716: 711: 703: 694:Fosun Industrial 691: 690: 685: 634:SSE MidCap Index 624:As of 2018, the 588: 585: 583: 560: 559: 536: 530: 529: 516: 515: 493: 492: 469: 463: 462: 449: 448: 426: 425: 402: 396: 395: 394:上海復星醫藥(集團)股份有限公司 382: 381: 380:上海复星医药(集团)股份有限公司 348:Fosun Industrial 340:Fosun Long March 309: 308: 286: 285: 279: 269: 268: 262: 248: 242: 241: 200: 199: 90: 89: 49: 42: 21: 2425: 2424: 2420: 2419: 2418: 2416: 2415: 2414: 2340: 2339: 2338: 2333: 2297:Sinovac Biotech 2290:Sinopharm Group 2171: 2161: 2159: 2122: 2121: 2118: 2117: 2116: 2101: 2097: 2092: 2087: 2086: 2076: 2074: 2069: 2068: 2064: 2054: 2052: 2035: 2034: 2030: 2020: 2018: 2009: 2008: 2004: 1994: 1992: 1983: 1982: 1978: 1968: 1966: 1957: 1956: 1947: 1930: 1929: 1925: 1915: 1913: 1912:(Press release) 1903: 1902: 1898: 1888: 1886: 1877: 1876: 1872: 1862: 1860: 1851: 1850: 1846: 1836: 1834: 1825: 1824: 1820: 1810: 1808: 1807:. 20 April 2020 1799: 1798: 1794: 1784: 1782: 1774: 1773: 1769: 1753: 1752: 1748: 1738: 1736: 1732: 1728: 1727: 1723: 1713: 1711: 1708:Financial Times 1700: 1699: 1695: 1685: 1683: 1679: 1672: 1671: 1667: 1657: 1655: 1645: 1644: 1640: 1630: 1628: 1624: 1620: 1619: 1615: 1605: 1603: 1600:Financial Times 1591: 1590: 1586: 1576: 1574: 1566: 1565: 1561: 1551: 1549: 1546:Financial Times 1537: 1536: 1532: 1522: 1520: 1511: 1510: 1506: 1496: 1494: 1484: 1483: 1479: 1469: 1467: 1460: 1456: 1455: 1451: 1441: 1439: 1435: 1431: 1430: 1426: 1416: 1414: 1410: 1403: 1399: 1398: 1394: 1380: 1378: 1371: 1367: 1366: 1362: 1352: 1350: 1346: 1339: 1335: 1334: 1323: 1313: 1311: 1307: 1300: 1296: 1295: 1291: 1281: 1279: 1269: 1268: 1264: 1254: 1252: 1245: 1241: 1240: 1233: 1223: 1221: 1219:PharmaBoardroom 1213: 1212: 1208: 1198: 1196: 1188: 1187: 1183: 1173: 1171: 1163: 1162: 1158: 1148: 1146: 1141: 1140: 1136: 1126: 1124: 1112: 1111: 1107: 1097: 1095: 1091: 1085: 1084: 1069: 1064: 1059: 1058: 1037: 1033: 1027:Sinopharm Group 1021: 1017: 1011:Sinopharm Group 1009: 1005: 1000: 951: 851: 839:Financial Times 816:Financial Times 770:Sinopharm Group 661: 648: 596: 580: 275: 258: 246: 235: 196: 189: 185: 175: 145: 128: 83: 66: 35: 28: 23: 22: 15: 12: 11: 5: 2423: 2421: 2413: 2412: 2410:Chinese brands 2407: 2402: 2397: 2392: 2387: 2382: 2377: 2372: 2367: 2362: 2357: 2352: 2342: 2341: 2335: 2334: 2332: 2331: 2329: 2324: 2319: 2314: 2309: 2304: 2299: 2294: 2293: 2292: 2282: 2277: 2272: 2267: 2262: 2257: 2252: 2247: 2242: 2237: 2232: 2227: 2222: 2217: 2212: 2207: 2202: 2197: 2192: 2187: 2182: 2176: 2173: 2172: 2160: 2158: 2157: 2150: 2143: 2135: 2129: 2128: 2102: 2095: 2094: 2093: 2091: 2090:External links 2088: 2085: 2084: 2062: 2028: 2002: 1976: 1945: 1923: 1896: 1885:. 9 April 2020 1870: 1844: 1818: 1792: 1767: 1746: 1721: 1693: 1665: 1638: 1613: 1584: 1559: 1530: 1504: 1477: 1449: 1424: 1392: 1360: 1321: 1289: 1262: 1231: 1206: 1181: 1156: 1134: 1105: 1066: 1065: 1063: 1060: 1057: 1056: 1031: 1015: 1002: 1001: 999: 996: 984:Guo Guangchang 955:ordinary share 950: 947: 945:for BNT162b2. 850: 847: 824:Sisram Medical 808:mainland China 751:Guo Guangchang 660: 657: 656: 655: 652: 647: 644: 602: 601: 590: 589: 578: 574: 573: 570: 569: 566: 565: 562: 561: 558:Fù xīng shí yè 554: 548: 547: 541: 540: 539:Transcriptions 532: 531: 524: 518: 517: 510: 504: 503: 499: 498: 495: 494: 491:fù xīng yī yào 487: 481: 480: 474: 473: 472:Transcriptions 465: 464: 457: 451: 450: 443: 437: 436: 432: 431: 428: 427: 420: 414: 413: 407: 406: 405:Transcriptions 398: 397: 390: 384: 383: 376: 370: 369: 365: 364: 361: 360: 357: 356: 353: 352: 349: 345: 344: 341: 337: 336: 333: 329: 328: 325: 323:Sisram Medical 319: 318: 315: 306: 300: 299: 293: 289: 288: 280: 272: 271: 263: 255: 254: 236: 231: 228: 227: 224: 220: 219: 216: 215: 212: 208: 207: 204: 197: 194: 191: 190: 187: 183: 181: 177: 176: 174: 173: 170: 167: 161: 159: 155: 154: 151: 147: 146: 144: 143: 140: 139:pharmaceutical 136: 134: 130: 129: 127: 126: 121: 118: 117: 116:(H share) 114: 104: 103: 102:(A share) 100: 86: 84: 79: 76: 75: 72: 68: 67: 65: 64: 61: 57: 55: 51: 50: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 2422: 2411: 2408: 2406: 2403: 2401: 2398: 2396: 2393: 2391: 2388: 2386: 2383: 2381: 2378: 2376: 2373: 2371: 2368: 2366: 2363: 2361: 2358: 2356: 2353: 2351: 2348: 2347: 2345: 2330: 2328: 2325: 2323: 2320: 2318: 2315: 2313: 2310: 2308: 2307:Tong Ren Tang 2305: 2303: 2300: 2298: 2295: 2291: 2288: 2287: 2286: 2283: 2281: 2278: 2276: 2273: 2271: 2268: 2266: 2263: 2261: 2258: 2256: 2253: 2251: 2248: 2246: 2243: 2241: 2238: 2236: 2233: 2231: 2228: 2226: 2223: 2221: 2218: 2216: 2213: 2211: 2208: 2206: 2203: 2201: 2198: 2196: 2193: 2191: 2190:China Nepstar 2188: 2186: 2185:CSPC Zhongrun 2183: 2181: 2178: 2177: 2174: 2170: 2165: 2156: 2151: 2149: 2144: 2142: 2137: 2136: 2133: 2125: 2120: 2119: 2114: 2113: 2105: 2089: 2072: 2066: 2063: 2051: 2047: 2043: 2039: 2032: 2029: 2016: 2012: 2006: 2003: 1990: 1986: 1980: 1977: 1964: 1960: 1954: 1952: 1950: 1946: 1940: 1935: 1927: 1924: 1911: 1907: 1900: 1897: 1884: 1880: 1874: 1871: 1859: 1855: 1848: 1845: 1832: 1831:Bloomberg.com 1828: 1822: 1819: 1806: 1802: 1796: 1793: 1781: 1777: 1771: 1768: 1763: 1762: 1757: 1750: 1747: 1731: 1725: 1722: 1709: 1704: 1697: 1694: 1678: 1677: 1669: 1666: 1653: 1649: 1642: 1639: 1623: 1617: 1614: 1601: 1596: 1588: 1585: 1573: 1569: 1563: 1560: 1547: 1542: 1534: 1531: 1518: 1514: 1508: 1505: 1492: 1488: 1481: 1478: 1465: 1461: 1453: 1450: 1434: 1428: 1425: 1408: 1404: 1396: 1393: 1388: 1376: 1372: 1364: 1361: 1344: 1340: 1332: 1330: 1328: 1326: 1322: 1305: 1301: 1293: 1290: 1277: 1273: 1266: 1263: 1250: 1246: 1238: 1236: 1232: 1220: 1216: 1210: 1207: 1195: 1194:Bloomberg.com 1191: 1185: 1182: 1170: 1166: 1160: 1157: 1144: 1138: 1135: 1122: 1121: 1116: 1109: 1106: 1090: 1089: 1082: 1080: 1078: 1076: 1074: 1072: 1068: 1061: 1049: 1041: 1035: 1032: 1028: 1024: 1019: 1016: 1012: 1007: 1004: 997: 995: 993: 989: 985: 980: 978: 973: 971: 966: 964: 960: 956: 948: 946: 944: 940: 935: 933: 929: 925: 920: 918: 913: 912: 908: 906: 900: 899: 895: 892: 888: 884: 880: 875: 874: 873: 867: 865: 861: 856: 855: 848: 846: 844: 840: 836: 831: 829: 825: 820: 818: 817: 811: 809: 805: 800: 798: 793: 792:(Sinopharm). 791: 783: 775: 771: 766: 764: 760: 756: 752: 744: 736: 728: 724: 719: 707: 699: 695: 681: 677: 673: 669: 666: 658: 653: 650: 649: 645: 643: 641: 640: 635: 631: 630:SSE 180 Index 627: 622: 620: 616: 612: 608: 600: 595: 591: 587: 579: 575: 571: 567: 555: 553: 549: 546: 542: 537: 533: 525: 523: 519: 511: 509: 505: 500: 488: 486: 482: 479: 475: 470: 466: 458: 456: 452: 444: 442: 438: 433: 421: 419: 415: 412: 408: 403: 399: 391: 389: 385: 377: 375: 371: 366: 362: 358: 350: 347: 346: 342: 339: 338: 334: 331: 330: 326: 324: 321: 320: 316: 314: 311: 310: 307: 305: 301: 297: 294: 290: 281: 278: 273: 264: 261: 256: 252: 245: 237: 234: 229: 225: 221: 213: 210: 209: 205: 202: 201: 198: 192: 182: 178: 171: 168: 166: 163: 162: 160: 156: 152: 148: 141: 138: 137: 135: 131: 125: 122: 115: 113: 109: 106: 105: 101: 99: 95: 92: 91: 88: 87: 85: 82: 77: 73: 69: 62: 59: 58: 56: 52: 48: 43: 37: 33: 19: 2108: 2075:. Retrieved 2065: 2053:. Retrieved 2041: 2031: 2019:. Retrieved 2014: 2005: 1993:. Retrieved 1988: 1979: 1967:. Retrieved 1962: 1926: 1914:. Retrieved 1909: 1899: 1887:. Retrieved 1882: 1873: 1861:. Retrieved 1857: 1847: 1835:. Retrieved 1830: 1821: 1809:. Retrieved 1804: 1795: 1783:. Retrieved 1779: 1770: 1759: 1749: 1737:. Retrieved 1724: 1712:. Retrieved 1707: 1696: 1684:. Retrieved 1675: 1668: 1656:. Retrieved 1651: 1641: 1629:. Retrieved 1616: 1604:. Retrieved 1599: 1587: 1575:. Retrieved 1571: 1562: 1550:. Retrieved 1545: 1533: 1521:. Retrieved 1516: 1507: 1495:. Retrieved 1490: 1480: 1468:. Retrieved 1463: 1452: 1440:. Retrieved 1427: 1415:. Retrieved 1406: 1395: 1385:– via 1379:. Retrieved 1374: 1363: 1351:. Retrieved 1342: 1312:. Retrieved 1303: 1292: 1280:. Retrieved 1275: 1265: 1253:. Retrieved 1248: 1222:. Retrieved 1218: 1209: 1197:. Retrieved 1193: 1184: 1172:. Retrieved 1168: 1159: 1147:. Retrieved 1137: 1125:. Retrieved 1118: 1108: 1096:. Retrieved 1087: 1052:復星實業(香港)有限公司 1044:复星实业(香港)有限公司 1034: 1018: 1006: 981: 974: 967: 952: 949:Shareholders 936: 921: 914: 910: 909: 901: 897: 896: 887:mRNA vaccine 876: 869: 868: 860:nucleic acid 857: 853: 852: 838: 832: 821: 814: 812: 801: 794: 767: 755:Liang Xinjun 722: 720: 693: 684:上海复星实业股份有限公司 675: 670:in 1998 and 662: 637: 623: 615:Fosun Pharma 614: 606: 605: 593: 584:.fosunpharma 552:Hanyu Pinyin 485:Hanyu Pinyin 418:Hanyu Pinyin 368:Chinese name 332:Gland Pharma 304:Subsidiaries 277:Total equity 260:Total assets 253: (2017) 180:Headquarters 172:and 3 others 71:Company type 36: 2327:WuXi AppTec 2205:Guangyuyuan 2111:(Q11071241) 2055:21 November 2021:21 November 1995:21 November 1969:21 November 1916:21 November 1889:21 November 1863:10 November 1837:1 September 1811:1 September 1785:1 September 1654:. Hong Kong 1577:20 November 1493:. Hong Kong 1464:Apple Daily 1278:. Hong Kong 1224:7 September 1199:7 September 1174:20 December 1123:. Hong Kong 988:Wang Qunbin 759:Wang Qunbin 296:Fosun Int'l 249:3.125  2344:Categories 1761:TechCrunch 1459:復星醫藥減持國藥控股 1062:References 646:Key people 611:trade name 233:Net income 206:(chairman) 195:Key people 2077:28 August 2050:0362-4331 1805:GenomeWeb 998:Footnotes 928:Hong Kong 917:Phase III 211:Wu Yifang 203:Chen Qiyu 81:Traded as 2375:H shares 1739:5 August 1714:5 August 1686:5 August 1658:5 August 1631:5 August 1606:5 August 1602:. London 1552:5 August 1523:5 August 1497:6 August 1470:6 August 1442:6 August 1417:5 August 1381:5 August 1353:5 August 1314:5 August 1282:5 August 1255:5 August 1149:5 August 1127:1 August 1098:5 August 959:A shares 883:BioNTech 879:BioNTech 872:BNT162b2 849:COVID-19 731:上海复星实业公司 626:A shares 327:(52.83%) 298:(37.94%) 223:Services 184:Shanghai 133:Industry 54:Formerly 2104:Scholia 1963:Reuters 1934:medRxiv 1858:Reuters 1402:2009年年报 1338:2003年年报 1299:1999年年报 963:H share 782:Chinese 774:Chinese 763:Fan Wei 743:Chinese 735:Chinese 727:Chinese 706:Chinese 698:Chinese 680:Chinese 678:(SFIC; 672:H share 665:A share 659:History 577:Website 251:billion 158:Founder 150:Founded 142:medical 110::  2048:  1936:  1409:] 1345:] 1306:] 1169:Forbes 1050:: 1042:: 939:Pfizer 891:Pfizer 786:国药产业投资 784:: 776:: 745:: 737:: 729:: 715:股份有限公司 708:: 700:: 682:: 351:(100%) 343:(100%) 98:600196 74:listed 2302:Tasly 1733:(PDF) 1680:(PDF) 1625:(PDF) 1436:(PDF) 1411:(PDF) 1405:[ 1375:企业观察报 1347:(PDF) 1341:[ 1308:(PDF) 1302:[ 1247:[ 1092:(PDF) 932:Macau 739:复星高科技 335:(12%) 292:Owner 214:(CEO) 188:China 2079:2019 2057:2020 2046:ISSN 2023:2020 1997:2020 1971:2020 1918:2020 1891:2020 1865:2020 1839:2020 1813:2020 1787:2020 1741:2018 1716:2018 1688:2018 1660:2018 1633:2018 1608:2018 1579:2020 1554:2018 1525:2018 1499:2018 1472:2018 1444:2018 1419:2018 1387:Sina 1383:2018 1355:2018 1316:2018 1284:2018 1257:2018 1226:2020 1201:2020 1176:2020 1151:2018 1129:2018 1100:2018 992:HK$ 986:and 930:and 924:HKSE 835:A.G. 778:国药控股 761:and 747:广信科技 586:.com 528:復星實業 514:复星实业 461:復星醫藥 447:复星医药 153:1994 112:2196 108:SEHK 864:FDA 597:in 582:www 244:CN¥ 94:SSE 2346:: 2044:. 2040:. 2013:. 1987:. 1961:. 1948:^ 1908:. 1881:. 1856:. 1829:. 1803:. 1778:. 1758:. 1706:. 1650:. 1598:. 1570:. 1544:. 1515:. 1489:. 1373:. 1324:^ 1274:. 1234:^ 1217:. 1192:. 1167:. 1117:. 1070:^ 1046:; 957:: 934:. 810:. 765:. 757:, 753:, 710:医药 702:实业 689:复星 621:. 613:: 186:, 96:: 2154:e 2147:t 2140:v 2115:. 2081:. 2059:. 2025:. 1999:. 1973:. 1942:. 1920:. 1893:. 1867:. 1841:. 1815:. 1789:. 1764:. 1718:. 1662:. 1610:. 1581:. 1556:. 1527:. 1501:. 1474:. 1389:. 1286:. 1228:. 1203:. 1178:. 1153:. 1131:. 772:( 725:( 609:( 247:0 34:. 20:)

Index

Fosun Pharmaceutical
Shanghai Pharmaceuticals

Traded as
SSE
600196
SEHK
2196
SSE MidCap Component
Fosun High Technology
Net income
CN¥
billion
Total assets
Total equity
Fosun Int'l
Subsidiaries
Sinopharm Industrial Investment
Sisram Medical
Simplified Chinese
Traditional Chinese
Standard Mandarin
Hanyu Pinyin
Simplified Chinese
Traditional Chinese
Standard Mandarin
Hanyu Pinyin
Simplified Chinese
Traditional Chinese
Standard Mandarin

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.